The Science and Technology Development Fund (STDF), Ministry of Scientific Research, granted an EGP 5,000,000 fund to our professors at the School of Pharmacy Dr. Medhat Al-Ghobashy, Dr. Muhammad Al Shorbagy, Dr. Muhammed Abdallah and Dr. Ahmed Sherif Attia; in collaboration with Minapharm Biogenetics and researchers from Cairo University.
This pioneering research is for the production and quality assessment of a biosimilar therapeutic monoclonal antibody for the treatment of breast cancer is the newest addition to the NGU research initiatives.
